Search research articles
Contact Us
Filters
Showing results (251-260 of 312) with videos related to
Page
of 32
Sort By:
The Journal of Biological Chemistry
|
September 12, 2020
Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2
Michael J Edwards, Katrin Anne Becker, Barbara Gripp, et al.
International Journal of Oncology
|
October 14, 2014
Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany
Elgar Susanne Quabius, Jochen Haag, André Kühnel, et al.
Ebiomedicine
|
December 20, 2021
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
Rüdiger Groß, Michelle Zanoni, Alina Seidel, et al.
Frontiers in Immunology
|
August 12, 2022
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults
Alina Seidel, Michelle Zanoni, Rüdiger Groß, et al.
The Lancet. Infectious Diseases
|
April 15, 2022
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
Viruses
|
January 8, 2025
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients
Philippa von der Schulenburg, Georg M N Behrens, Markus Hoffmann, et al.
Plos Pathogens
|
November 13, 2024
ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization
Lu Zhang, Hsiu-Hsin Cheng, Nadine Krüger, et al.
Cell
|
April 1, 2021
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann, Prerna Arora, Rüdiger Groß, et al.
The Journal of Infection
|
July 5, 2023
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial
Christian Taucher, Rajeka Lazarus, Hanna Dellago, et al.
Journal of the American Chemical Society
|
September 24, 2011
Belt-shaped π-systems: relating geometry to electronic structure in a six-porphyrin nanoring
Johannes K Sprafke, Dmitry V Kondratuk, Michael Wykes, et al.
Page
of 32
Search research articles
Search
Showing results (251-260 of 312) with videos related to
Sort By:
Page
of 32
The Journal of Biological Chemistry
|
September 12, 2020
Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2
Michael J Edwards, Katrin Anne Becker, Barbara Gripp, et al.
International Journal of Oncology
|
October 14, 2014
Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany
Elgar Susanne Quabius, Jochen Haag, André Kühnel, et al.
Ebiomedicine
|
December 20, 2021
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
Rüdiger Groß, Michelle Zanoni, Alina Seidel, et al.
Frontiers in Immunology
|
August 12, 2022
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults
Alina Seidel, Michelle Zanoni, Rüdiger Groß, et al.
The Lancet. Infectious Diseases
|
April 15, 2022
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
Viruses
|
January 8, 2025
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients
Philippa von der Schulenburg, Georg M N Behrens, Markus Hoffmann, et al.
Plos Pathogens
|
November 13, 2024
ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization
Lu Zhang, Hsiu-Hsin Cheng, Nadine Krüger, et al.
Cell
|
April 1, 2021
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann, Prerna Arora, Rüdiger Groß, et al.
The Journal of Infection
|
July 5, 2023
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial
Christian Taucher, Rajeka Lazarus, Hanna Dellago, et al.
Journal of the American Chemical Society
|
September 24, 2011
Belt-shaped π-systems: relating geometry to electronic structure in a six-porphyrin nanoring
Johannes K Sprafke, Dmitry V Kondratuk, Michael Wykes, et al.
Page
of 32